Biomarin Pharmaceutical Inc (BMRN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BMRN Annual Balance Sheets →
Looking at balance sheet data from Biomarin Pharmaceutical Inc through Jun 30 2025 provides insight into Jun 30 2026's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent874.01
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments874.00
Accounts receivable1,061.05
Inventories1,782.52
Other Current Assets254.05
Total Current Assets3,971.62
Equipment/Property/Plant Net2,101.03
Goodwill net655.75
Intangible Assets4,879.37
Long-term investments0.00
Other Assets, Noncurrent115.68
Total Assets11,723.44
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1,005.79
Accrued Liabilities, Current220.51
Financial Instruments33.53
Convertible Debt, Current LO658.20
Taxes Payable9.14
Total Current Liabilities1,664.00
Long-term debt4,186.14
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt4,186.14
Other liabilities, Noncurrent0.00
Total Liabilities5,401.75
Stockholders' Equity
Common Stock Value0.19
Additional Paid In Capital Common Stock6,037.02
Retained Earnings / Accumulated Deficit304.50
Accumulated Other Comprehensive Income-8.78
Defined Benefit Plan and Other11.23
Other Equity-8.78
Common Stockholder's Equity6,321.69
Total Stockholder's Equity6,321.69
Liabilities & Stockholder's Equity11,723.44
4 historic quarters locked

Sign in to unlock the full Biomarin Pharmaceutical Inc balance sheet history.

About Biomarin Pharmaceutical Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001048477-26-000016

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.